ACORN CAPITAL ADVISORS, LLC Long-Term Concentrated

CIK: 0002054410 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 19, 2025

Total Value ($000): $149,945 (100.0% shares, 0.0% debt)

Holdings (22)

CGON CG ONCOLOGY INC 18.5%
Value ($000) $27,722 Shares 1,131,501 Est. Cost $34.21 Unrealized -17.8%
URGN UROGEN PHARMA LTD 11.2%
Value ($000) $16,770 Shares 1,516,303 Est. Cost $11.97 Unrealized -11.0%
Y-MABS THERAPEUTICS INC 9.6%
Value ($000) $14,333 Shares 3,235,387 Est. Cost $7.44 Unrealized
TRVI TREVI THERAPEUTICS INC 9.0%
Value ($000) $13,491 Shares 2,144,844 Est. Cost $3.31 Unrealized +44.3%
CADL CANDEL THERAPEUTICS INC 8.1%
Value ($000) $12,160 Shares 2,152,252 Est. Cost $6.13 Unrealized +33.3%
PBYI PUMA BIOTECHNOLOGY INC 7.8%
Value ($000) $11,663 Shares 3,940,052 Est. Cost $2.91 Unrealized +7.6%
BCAX BICARA THERAPEUTICS 5.6%
Value ($000) $8,383 Shares 643,382 Est. Cost $20.81 Unrealized -36.2%
TARA PROTARA THERAPEUTICS INC 3.6%
Value ($000) $5,452 Shares 1,279,800 Est. Cost $3.23 Unrealized +38.3%
TERN TERNS PHARMACEUTICALS INC 3.6%
Value ($000) $5,441 Shares 1,971,264 Est. Cost $6.77 Unrealized -39.7%
OKUR ONKURE THERAPEUTICS INC 3.4%
Value ($000) $5,124 Shares 1,439,674 Est. Cost $15.14 Unrealized -62.9%
VSTM VERASTEM INC 3.1%
Value ($000) $4,700 Shares 779,498 Est. Cost $3.94 Unrealized +55.1%
HELP CYBIN INC 3.1%
Value ($000) $4,663 Shares 734,394 Est. Cost $10.16 Unrealized -14.7%
CRDF CARDIF ONCOLOGY INC 3.0%
Value ($000) $4,529 Shares 1,442,308 Est. Cost $3.13 Unrealized +26.5%
OPTINOSE INC 2.6%
Value ($000) $3,877 Shares 422,814 Est. Cost $6.68 Unrealized
WHWK WHITEHAWK THERAPEUTICS INC 1.4%
Value ($000) $2,028 Shares 1,139,363 Est. Cost $2.27 Unrealized +15.3%
X4 PHARMACEUTICALS INC 1.2%
Value ($000) $1,755 Shares 7,310,650 Est. Cost $0.73 Unrealized
MURAL ONCOLOGY PLC 1.1%
Value ($000) $1,600 Shares 1,269,715 Est. Cost $3.22 Unrealized
AURA AURA BIOSCIENCES INC 1.0%
Value ($000) $1,453 Shares 590,508 Est. Cost $7.57 Unrealized 0.0%
BCAB BIOATLA INC 0.9%
Value ($000) $1,411 Shares 4,032,046 Est. Cost $1.68 Unrealized -74.5%
QTTB Q32 BIO INC. 0.9%
Value ($000) $1,326 Shares 803,425 Est. Cost $31.58 Unrealized -91.5%
VYNE VYNE THERAPEUTICS INC 0.8%
Value ($000) $1,242 Shares 785,938 Est. Cost $2.55 Unrealized -3.5%
ACRV ACRIVON THERAPEUTICS INC 0.5%
Value ($000) $823 Shares 405,237 Est. Cost $7.27 Unrealized -25.9%